BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3876995)

  • 1. Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducreyi to human serum.
    Odumeru JA; Wiseman GM; Ronald AR
    Infect Immun; 1985 Nov; 50(2):495-9. PubMed ID: 3876995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum.
    Ciurana B; Tomás JM
    Infect Immun; 1987 Nov; 55(11):2741-6. PubMed ID: 3312009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.
    Frisk A; Ahmed HJ; Van Dyck E; Lagergård T
    Microb Pathog; 1998 Aug; 25(2):67-75. PubMed ID: 9712686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of normal and immune sera on Haemophilus ducreyi 35000HP and its isogenic MOMP and LOS mutants.
    Hiltke TJ; Bauer ME; Klesney-Tait J; Hansen EJ; Munson RS; Spinola SM
    Microb Pathog; 1999 Feb; 26(2):93-102. PubMed ID: 10090856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the susceptibility of Pseudomonas aeruginosa to complement-mediated killing: role of antibodies to the rough lipopolysaccharide on serum-sensitive strains.
    Schiller NL
    Infect Immun; 1988 Mar; 56(3):632-9. PubMed ID: 3125110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virulence factors of Haemophilus ducreyi.
    Odumeru JA; Wiseman GM; Ronald AR
    Infect Immun; 1984 Feb; 43(2):607-11. PubMed ID: 6607219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum resistance in Haemophilus ducreyi requires outer membrane protein DsrA.
    Elkins C; Morrow KJ; Olsen B
    Infect Immun; 2000 Mar; 68(3):1608-19. PubMed ID: 10678980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel lectin, DltA, is required for expression of a full serum resistance phenotype in Haemophilus ducreyi.
    Leduc I; Richards P; Davis C; Schilling B; Elkins C
    Infect Immun; 2004 Jun; 72(6):3418-28. PubMed ID: 15155648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of lipopolysaccharide in complement-killing of Aeromonas hydrophila strains of serotype O:34.
    Merino S; Camprubí S; Tomás JM
    J Gen Microbiol; 1991 Jul; 137(7):1583-90. PubMed ID: 1955853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutropenia restores virulence to an attenuated Cu,Zn superoxide dismutase-deficient Haemophilus ducreyi strain in the swine model of chancroid.
    San Mateo LR; Toffer KL; Orndorff PE; Kawula TH
    Infect Immun; 1999 Oct; 67(10):5345-51. PubMed ID: 10496915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killing of dsrA mutants of Haemophilus ducreyi by normal human serum occurs via the classical complement pathway and is initiated by immunoglobulin M binding.
    Abdullah M; Nepluev I; Afonina G; Ram S; Rice P; Cade W; Elkins C
    Infect Immun; 2005 Jun; 73(6):3431-9. PubMed ID: 15908371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid.
    Lagergård T
    Microb Pathog; 1992 Sep; 13(3):203-17. PubMed ID: 1291843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid.
    Afonina G; Leduc I; Nepluev I; Jeter C; Routh P; Almond G; Orndorff PE; Hobbs M; Elkins C
    Infect Immun; 2006 Apr; 74(4):2224-32. PubMed ID: 16552053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological basis of serum resistance of Neisseria gonorrhoeae.
    Schneider H; Griffiss JM; Williams GD; Pier GB
    J Gen Microbiol; 1982 Jan; 128(1):13-22. PubMed ID: 6806436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-pathogen interplay of Haemophilus ducreyi.
    Janowicz DM; Li W; Bauer ME
    Curr Opin Infect Dis; 2010 Feb; 23(1):64-9. PubMed ID: 19918177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies against Haemophilus lipopolysaccharides: clone DP8 specific for Haemophilus ducreyi and clone DH24 binding to lacto-N-neotetraose.
    Borrelli S; Roggen EL; Hendriksen D; Jonasson J; Ahmed HJ; Piot P; Jansson PE; Lindberg AA
    Infect Immun; 1995 Jul; 63(7):2665-73. PubMed ID: 7790083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of complement in defense of the middle ear revealed by restoring the virulence of nontypeable Haemophilus influenzae siaB mutants.
    Figueira MA; Ram S; Goldstein R; Hood DW; Moxon ER; Pelton SI
    Infect Immun; 2007 Jan; 75(1):325-33. PubMed ID: 17088344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of skin adherence, penetration and tissue necrosis production by Haemophilus ducreyi, the causative agent of chancroid.
    Abeck D; Korting HC
    Acta Derm Venereol Suppl (Stockh); 1992; 174():1-20. PubMed ID: 1636361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialic acid-containing lipopolysaccharides of Salmonella O48 strains--potential role in camouflage and susceptibility to the bactericidal effect of normal human serum.
    Bugla-Płoskońska G; Rybka J; Futoma-Kołoch B; Cisowska A; Gamian A; Doroszkiewicz W
    Microb Ecol; 2010 Apr; 59(3):601-13. PubMed ID: 19844648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.